At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Role within BIOMAP
The Inflammation and Immunology Research Unit and the Clinical Development group at Pfizer will contribute to the BIOMAP project with contributors located in Germany and The United States. The contributors have backgrounds in discovery research, clinical research, sample management and data analysis. Pfizer will provide clinical data and biospecimens from subjects with mild to moderate psoriasis or atopic dermatitis to BIOMAP and specific expertise related to large dataset analyses and interpretation of data in relation to each disease under study.